文章摘要
崔为国,薛秀娟,刘佳,孙国清,刘春华,田随安,王哲,李韩平,李敬云.河南省沈丘县抗病毒治疗者HIV耐药株流行状况调查[J].中华流行病学杂志,2013,34(3):218-220
河南省沈丘县抗病毒治疗者HIV耐药株流行状况调查
A CROSS-sectional study on the prevalence of HIV drug resistance in patients parking antiretroviral treatment in Shenqiu county,Henan province
收稿日期:2012-09-29  出版日期:2014-09-26
DOI:
中文关键词: 艾滋病病毒  抗病毒治疗  耐药
英文关键词: HIV  Antiretroviral therapy  Drug resistance
基金项目:河南省医学科技攻关计划省部共建项目(2011010016);河南省创新型科技人才队伍建设工程
作者单位E-mail
崔为国 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
薛秀娟 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
刘佳 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
孙国清 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
刘春华 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
田随安 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所  
王哲 450016 郑州, 河南省疾病预防控制中心性病艾滋病预防控制所 wangzhe@hncdc.corn.cn 
李韩平 军事医学科学院微生物流行病研究所  
李敬云 军事医学科学院微生物流行病研究所 lijy@nic.bmi.ac.cn 
摘要点击次数: 2725
全文下载次数: 908
中文摘要:
      目的 了解河南省沈丘县艾滋病长期治疗患者耐药情况.方法 对沈丘县120例于2003年开始接受抗病毒治疗的艾滋病患者进行横断面研究,同时测定其病毒载量(VL)和CD4+T淋巴细胞计数,对VL>1000 copies/ml的患者进行In-house方法基因型耐药检测.结果 120例患者中有114例获得VL数据,其中33例小于检测限(50 copies/ml),其余81例VL均值为lg(4.09±1.10)copies/ml.所有患者CD4<\sub>+<\sup>T淋巴细胞计数的均值为(377±218) cells/ml,其中64例(53.3%)均值> 350 cells/ml.67例患者检测基因型耐药性,成功测序的58例中有40例产生反转录酶抑制剂耐药(RTIs),核苷类反转录酶抑制剂(NRTIs)、非核苷类反转录酶抑制剂(NNRTIs)的耐药发生率分别为53.4%(31/58)、67.2% (39/58).三种治疗方案耐药发生比例无差异,NRTIs、NNRTIs两类药物中齐多夫定、拉米夫定、奈韦拉平的耐药发生率较高,未发现蛋白酶抑制剂耐药.结论 河南省沈丘县艾滋病患者耐药毒株流行较严重,应长期随访监测,及时优化治疗方案.
英文摘要:
      Objective To understand the prevalence of drug resistance in AIDS patients who had been receiving HAART in a long run,in Shenqiu county,Henan province.Methods This crosssectional study included 120 HIV infected patients who began receiving ART (antiretroviral therapy) in 2003.Viral loads and CD4 +T cells counts were measured,and In-house drug resistance test was performed in VL > 1000 copies/ml patients.Results 114 cases out of 120 patients had complete viral load data.Among them,33 cases having viral loads less than 50 copies/ml,and the remaining viral loads showed an average of lg (4.09 ± 1.10) copies/ml.The average of CD4+ T cell counts was (377 ±2 1 8) cells/ml,with 64 (53.3%) cases showing their CD4+ T cell counts higher than 350 cells/ml.In 67 patients,58 of them showed genotypic resistance,and 40 cases showed reverse transcriptase inhibitors (RTIs) resistance.The ratios of nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) resistance were 53.4% (31/58) and 67.2% (39/58),respectively.There were no differences of drug resistance ratio in the three treatment programs.The highest drug resistance rates in NRTIs and NNRTIs were zidovudine,lamivudin,nevirapine.However,protease inhibitors (PIs) resistance variants were not found.Conclusion The prevalence of drug-resistant strains seemed to be high in Shenqiu country,Henan province.Long-term follow-up monitoring strategy should be developed to optimize the timely treatment programs.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭